University of Illinois at Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Illinois at Chicago sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
University of Illinois at Chicago: 430 sponsored US clinical trials, 115 recruiting.
University of Illinois at Chicago sponsors 430 registered US clinical trials on ClinicalTrials.gov, 115 of them currently recruiting, and 236 completed. 30 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 10 trials.
Top-decile sponsor footprint
University of Illinois at Chicago ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 271 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 3 of 9
My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
NCT05208164
Sleep, Diabetic Retinopathy and Melatonin
NCT04547439
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
NCT02347111
Cortical Priming to Optimize Gait Rehabilitation in Stroke: a Renewal
NCT04477330
Analysis of Human ALS Tissues and Registry of ALS Patients
NCT05067179
Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC)
NCT04427293
BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron
NCT04150614
Convalescent Plasma as a Possible Treatment for COVID-19
NCT04442191
BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)
NCT04187105
DNA Methylation and Vascular Function
NCT03527420
Alternative Therapies for Improving Physical Function in Individuals With Stroke
NCT03869138
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
NCT06374537
Lidocaine Infusion in Pancreatic Cancer
NCT04048278
Reactive Balance Training for Fall Prevention
NCT04205279
Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
NCT03121001
Artificial Intelligence (AI)-Based Intraoperative Visualization is Increasingly Integrated Into Robotic Surgery Platforms; However, Its Impact on Surgeons' Cognitive Workload Remains Unclear. This Study Evaluated Perceived Workload Among Console Surgeons and Bedside Assistants According to Different
NCT07566078
Sickle Cell, Pain and Mediterranean Diet
NCT06886477
Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero
NCT05929521
Exploratory Trial of a Pediatric Web-Based Care Planning Guide
NCT06458959
Lifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple Sclerosis
NCT06355804
Well-being in Students and Teachers Study
NCT06203288
Exercise Training, Cognition, and Mobility in Older Adults With Multiple Sclerosis
NCT05930821
The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older
NCT05654142
Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern
NCT05251402
Culturally Smart Relationships Study
NCT05391711
The PATHway Study: Primary Care Based Depression Prevention in Adolescents
NCT05203198
Initial Correction Keratoconus
NCT04918316
We Walk Plus Study for Older Adults With Intellectual Disabilities
NCT04573530
Sleep Optimization to Improve Glycemic Control in Adults With Type 1 Diabetes
NCT04506151
Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
NCT04358900
Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression
NCT05331599
Investigation of Multi-Family Therapy for Anorexia Nervosa
NCT06203418
PATH 2 Purpose: Primary Care and Community-Based Prevention of Mental Disorders in Adolescents
NCT04290754
Curcumin in Kidney Transplant Recipients
NCT03935958
Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
NCT04083963
Child Development and Primary Care in Low Income Families
NCT03126292
Aging and Mixed Perturbation Training to Reduce Falls in Locomotion
NCT03199729
Uptake of Genetic Counseling Among African American Women
NCT04082117
Perturbation Training for Fall-risk Reduction Among Stroke Survivors
NCT03205527
Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
NCT03121014
Glucose Metabolism in Sickle Cell Disease
NCT02922296
Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)
NCT01499888
Effects, Metabolic Mechanisms and Predictors of Response to Acupuncture in Treating Psychoneurological Symptoms Among Breast Cancer Survivors
NCT07695948
Apple Watch Evaluation of Endodontics Occupational Stress
NCT07498348
Monitoring Occupational Dental Stress Using Apple Watch
NCT07356141
Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease
NCT06603012
Research Investigating Drug Effects-2 (RiDE-2)
NCT06758596
Determining the Effects of Ischemic Conditioning and Neuromuscular Electrical Stimulation on Overall Function After Lower Limb Amputation
NCT07664995
GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
NCT07581405
Multi-Site Feasibility Testing a Meditation App for Youth in the Legal System
NCT07674303
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 37 |
| Phase 2 | 43 |
| Phase 3 | 11 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Illinois at Chicago pipeline
115 recruiting of 430 indexed (27% open); 236 completed (55%).
Phase mix: 30 late (III/IV) vs 80 early (I/II) (early-phase heavy).
Top condition: Multiple Sclerosis (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Illinois at Chicago: open-pipeline peers nationwide
Peers matched on 430 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
University of Illinois at Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this University of Illinois at Chicago page
430 registered trials is a research-attention snapshot, not an endorsement of University of Illinois at Chicago or any single study.
- 115 of University of Illinois at Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition University of Illinois at Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Illinois at Chicago pipeline card: 430 registered trials from official public datasets.Report a data error.